BAXTER AHB8611 ELECTROLYTE SOLUTION COMPOUND SODIUM LACTATE (HARTMANN'S SOLUTION) 5000ML

Kraj: Australia

Język: angielski

Źródło: APVMA (Australian Pesticides and Veterinary Medicines Authority)

Składnik aktywny:

CALCIUM CHLORIDE; POTASSIUM CHLORIDE; SODIUM LACTATE; SODIUM CHLORIDE

Dostępny od:

BAXTER HEALTHCARE PTY LTD

INN (International Nazwa):

sodium chloride(6g/L)+sodium lactate(3.22g/L) + others

Forma farmaceutyczna:

PARENTERAL LIQUID/SOLUTION/SUSPENSION

Skład:

CALCIUM CHLORIDE MINERAL-CALCIUM-SALT Active 0.27 g/L; POTASSIUM CHLORIDE MINERAL-POTASSIUM Active 0.4 g/L; SODIUM LACTATE MINERAL-SODIUM Active 3.22 g/L; SODIUM CHLORIDE MINERAL-SODIUM-SALT Active 6.0 g/L

Sztuk w opakowaniu:

5000mL

Klasa:

VM - Veterinary Medicine

Wyprodukowano przez:

BAXTER HEALTHCARE

Grupa terapeutyczna:

ALL ANIMALS

Dziedzina terapeutyczna:

NUTRITION & METABOLISM

Wskazania:

DEHYDRATION | ELECTROLYTE REPLACEMENT

Podsumowanie produktu:

Poison schedule: 0; Withholding period: WHP: NIL; Host/pest details: ALL ANIMALS: [DEHYDRATION, ELECTROLYTE REPLACEMENT]; Poison schedule: 0; Withholding period: ; Host/pest details: ALL ANIMALS: [DEHYDRATION, ELECTROLYTE REPLACEMENT]; For treatment of dehydration and for electrolyte replacement.Do not use unless solution is clear. Discontinue infusion if adverse reaction occurs. To be used by or under the supervision of a registered veterinary surgeon.

Status autoryzacji:

Registered

Data autoryzacji:

2023-07-01

Ulotka dla pacjenta

0
0
0
FOR
ANIMAL
TREATMENT
ONLY
C
Eaxtlzr
AHB8611
1
ELECTROLYTE SOLUTION
COMPOUND SODIUM LACTATE
(HARTMANN’S
SOLUTION)
5000
IA
-
ACTtVE
CONSnlWENTS
. EACH
UTRE
CONTAINS
-
SODIUM CHLORIDE
6.0 g
-
SODfUh4
LACTATE 3.22 g .
F’OTASStUM
CHLORIDE 0.40 g
-
CALCIUM
CHLORIDE
0.27
g
APPROXIMATE MIUIMOLES PER UTRE
-
SODIUM
l31-
POTASSIUM 5
-
CALCIUM 2
-
CHLORIDE 111
-
BICARBONATE (AS LACTATE)
29
APPROXIMATE
OSMOLALITY
274
most-n
FOR THE TREATMENT OF
OEHYDRATION
AND FOR THE ELECTROLYTE
REPlACEMENT IN ALL SPECIES
DTRECLLONS FOR USE
DO NOT USE
UNLESS SOLUTION
tS
CLEAR
DO
NOT
REMOVE
PLAS7lC PACK
OVERPOUCH
UNTIL JUST BEFORE
USE
DISCONTINUE
INFUSION
IF
AOVERSE
REACTION
OCCURS
AVOID STORAGE OF
SOLUTtON
PREPARED
WITH
ADDtltMS
TO BE
USED
BY OR UNDER THE
SUPERWON
Of A REGISTERED
VETERINARY
SURGEON
I
REMOVE
BLUE
TAG AN0 INSERT PLASTIC DELIVERY SPIKE OF AN
ADMINISTRATION SET THE VOLUME OF FLUID AN0 ROUTE OF
AOMIN1STRATION
DEPEND ON SPECIES AGE
AN0
DEGREE OF
HYDRATION
OF
THE
ANIMAL
UNOER
TREATMENT
WITHHOLDING
PERIOD
NIL
DtSPOSAL
DISPOSE OF EMPTY CONTAINER AND
OUTER
PACKAGING
BY
WRAPPING WITH PAPER AND PLACING IN GARBAGE
STORE BELOW
3.X
(ROOM TEMPERATURE)
NRA
4959OJOL
PAXTER
HEALTHCARE
PlY
LTD
.b
R
E
GI
STERED
TRADEMARK
1
E?AXTER
ORi’
OLD TooNGAEIBIE NSW AUST
R
ALIA
88-25.01-390A
JO

Charakterystyka produktu

Baxter Healthcare Pty. Limited
Telephone: [phone]
A.B.N. 43 000 392 781
Fax: [phone]
Postal Address:
P.O. Box 88, Toongabbie,
N.S.W. Australia 2146
1 Baxter Drive, Old Toongabbie,
N.S.W. Australia 2146
MATERIAL SAFETY DATA SHEET
_ _
_ _
_ _
_Page _1 / 4
_ _
n.a. = not applicable; n.d. = not defined; * = change
Dear Customer,
Re: Material Safety Data Sheet Information from Baxter Healthcare
In response to your request for a Material Safety Data Sheet for
products Manufactured or
Distributed By Baxter Healthcare, the relevant Sheet has been
attached.
If you require any additional information about the product please
contact your Baxter
Healthcare Sales representative or Baxter Healthcare Customer Service.
Yours Sincerely
Environmental, Health & Safety Manager
Baxter Healthcare Pty Ltd
02 9848 1111
BAXTER HEALTHCARE CORPORATION DISCLAIMER
“The information and recommendations presented here in are based on
sources believed
to be reliable as of the date hereof. BAXTER HEALTHCARE CORPORATION
makes no
representation as to the completeness of accuracy thereof. It is the
user’s responsibility to
determine the product’s suitability for its intended use, the
product’s safe use, and the
product’s proper disposal. No representations or warranties not
expressly set forth herein
are made hereunder, whether express of implied by operation of law or
otherwise,
including, but not limited to any implied warranties of
MERCHANTABILITY OR FITNESS.
BAXTER HEALTHCARE CORPORATION neither assumes nor authorised any
person to
assume for it, any other or ADDITIONAL LIABILITY OR RESPONSIBILITY
resulting from
the use of, or reliance upon, this information.”
Baxter Healthcare Pty. Limited
Telephone: [phone]
A.B.N. 43 000 392 781
Fax: [phone]
Postal Address:
P.O. Box 88, Toongabbie,
N.S.W. Australia 2146
1 Baxter Drive, Old Toongabbie,
N.S.W. Australia 2146
MATERIAL SAFETY DATA SHEET
_ _
_ _
_ _
_Page _2 / 4
_ _
n.a. = not applicable; n.d. = not defined; * = change
COMMON NAME:
Baxter Healthcare Solutions
MANUFAC